Page 242 - Read Online

Block et al. Hepatoma Res 2019;5:22 Hepatoma Research
DOI: 10.20517/2394-5079.2019.017

Correction Open Access

Correction: Three primary malignancies in 17 years
in a man with chronic hepatitis B

Peter D. Block , Brianna J. Shinn , Christopher G. Roth , Jeffrey P. Baliff , Ralph G. Zinner , Hie-Won
1
1
2
4
3
Hann 5
1 Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
2 Department of Radiology, Abdominal Imaging Division, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
3 Department of Pathology, Anatomy, & Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
4 Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
5 Liver Disease prevention Center, Division of Gastroenterology and Hepatology Thomas Jefferson University Hospital,
Philadelphia, PA 19107, USA.
Correspondence to: Dr. Hie-Won Hann, FAASLD, Professor of Medicine, Liver Disease Prevention Center, Division of
Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Email: hie-won.hann@jefferson.edu

Revised: 24 Jun 2019 Accepted: 24 Jun 2019 Published: 28 Jun 2019

The Case Report was published on 21 Jun 2019.

Received: First Decision: Revised: Accepted: Published: The author's statement of conflict of interest was confused with the original and published incorrectly due to the
negligence of the Editorial Office. Here is the correction:
Science Editor: Copy Editor: Production Editor:
Conflict of Interest:
Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the
National Advisory Board of Gilead Sciences.
Ralph Zinner: Bristol Myers Squibb, Merck
Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest.

We, Editorial Office of Hepatoma Research apologize for any inconvenience we may cause.

© The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0
International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
and indicate if changes were made.

www.hrjournal.net